Trial Profile
A retrospective, multicenter study of plerixafor in combination with G-CSF in patients with lymphoma or multiple myeloma
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 Oct 2016
Price :
$35
*
At a glance
- Drugs Plerixafor (Primary)
- Indications Stem cell mobilisation
- Focus Adverse reactions; Therapeutic Use
- 04 Oct 2016 New trial record